i3 Consult to Apply its CTR Reporting for Observational Studies in Pre-Approval and Post Marketing



Since the passing of the 21st Century Cures Act, observational studies have been a growing ally to traditional clinical research in the biopharmaceutical and medical device approval process, culminating in many companies to take the initiative to use real-world evidence. However many companies experience formidable “stop gaps” in amassing sufficient real world evidence.

As i3 Consult continues to offer its weekly clinical trial reports (CTR) at www.i3consult.com/i3-clinical-trials-report/ on new drug therapies currently in clinical trials worldwide, we are seeking to use our CTR database as real world evidence in helping our clients to address the following critical success issues:
  • Is the research sufficiently patient-focused?
  • Have sufficient observational studies been used in the pre approval and post market stages?
  • Are there further opportunities for observational study data to save you time and money in your current clinical trial investigation?
  • How observational studies can make a viable alternative to clinical trials or bridging studies
  • To identify stakeholders and determine what kind of observational research data is needed
Who will benefit from our CTR referral services:

1. Clinical project specialists
2. Clinical research associates
3. Compliance officers
4. Consultants/service providers
5. Data management and statistics personnel
6. Executive management
7. General/corporate counsel
8. Investigators
9. Managers
10. Manufacturing directors and supervisors
11. R&D staff
12. Regulatory/legislative affairs professionals
13. Risk management specialists
14. Strategic planning and business development staff
15. Study monitors
16. Study research coordinators
17. Study sponsors

Best regards,
Dr. Wallace Macindoe,
CEO & Founder of i3 Consult.
i3 Consult- Integrated Intelligence for Healthcare Industries.


Comments

Post a Comment

Popular posts from this blog

i3 Consult to Expand It's CTR Reporting for Observational Studies in Pre-Approval and Post Marketing for Mobile OS Application

Image
Back in December last year i3 Consult launched its  CTRReporting Services for Observational Studies (). Just to re-iterate the unique selling point of these services, i3 Consult through its weekly clinical trial reports (CTR) on new drug therapies currently in clinical trials worldwide, we are seeking to use our CTR database as real world evidence in helping our clients to address the following critical success issues:             • Is the research sufficiently patient-focused?             • Have sufficient observational studies been used in the pre-approval and post market stages?             • Are there further opportunities for observational study data to save you time and money in your current clinical trial investigation?             • How observational studies can make a viable alternative to clinical trials or bridging studies.             • To identify stakeholders and determine what kind of observational research data is needed. At i3 Consult we believe that
Read more

i3 Consult Launches Business Operations in East Africa

Image
Healthcare investment In the East African region has grown year-on-year in the past decade. The opportunities in the region are enormous, with a regional capital demand for the sector beyond $10 billion. Although no East African country has met the Abuja Declaration target of spending at least 15 percent of its GDP on its healthcare, Rwanda nonetheless is on course, financing 7.5 percent of its GDP on health services, followed by Uganda at 7.2 percent, Kenya 6 percent and Tanzania at 5.6 percent. This stark reality is counteracted by growing challenges associated with increasing incomes, one of the youngest workforces by region in the world, as well as changing consumer preferences for better healthcare provision and affordable healthcare insurance cover. The healthcare space in the East African region requires consultancy service providers like i3 Consult who can bring together experts across multiple verticals in the 4Ps of the healthcare space – pharma, provider, payo
Read more

Tips for Moderating Market Research for Health care Industry

Now-a-days market research is very much essential to run a business or an industry. Especially for healthcare business it is necessary to perform an analytic research as the research will help people to understand the latest market trend. Latest market trend or demand should be understood in order to stand out in the healthcare industry. There are several Healthcare Market Research Companies available that can help healthcare businesses by performing various research as well as survey works. They design their market research to peer into people’s mind. That is why moderating the healthcare market research is also very essential to get beneficial results. How to moderate Pharmaceutical Market Research? Now-a-days everything is moderating and that is why people should follow these below mentioned tips for moderating healthcare market research: First the representatives of healthcare research companies should keep themselves prepared. The researcher or moderators should stay ne
Read more